Related references
Note: Only part of the references are listed.The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy
Marie Strickland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway
Di Che et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Second cancers in MPN: Survival analysis from an international study
Monia Marchetti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Leukemia secondary to myeloproliferative neoplasms
Andrew J. Dunbar et al.
BLOOD (2020)
Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma
Junfeng Zhang et al.
Aging-US (2020)
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study
Tiziano Barbui et al.
LEUKEMIA (2019)
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
Barbara Mora et al.
CANCER MEDICINE (2019)
Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review
Monia Marchetti et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of JAK2V617F mutant allele burdens
Chia-Chen Hsu et al.
HAEMATOLOGICA (2018)
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
Paola Guglielmelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Anna Ravn Landtblom et al.
LEUKEMIA (2018)
GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
Ayalew Tefferi et al.
LEUKEMIA (2018)
Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data
Arianna Ghirardi et al.
BLOOD CANCER JOURNAL (2018)
Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of JAK2V617F mutant allele burdens
Chia-Chen Hsu et al.
HAEMATOLOGICA (2018)
Myelofibrosis Treatment Algorithm 2018
Ayalew Tefferi et al.
BLOOD CANCER JOURNAL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms
Chih-Cheng Chen et al.
HAEMATOLOGICA (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2-mutated myeloproliferative neoplasms
Chih-Cheng Chen et al.
HAEMATOLOGICA (2017)
InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines
Quan Li et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Konstantin Okonechnikov et al.
BIOINFORMATICS (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
Hans Carl Hasselbalch et al.
MEDIATORS OF INFLAMMATION (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Myeloproliferative Neoplasms A Contemporary Review
Ayalew Tefferi et al.
JAMA ONCOLOGY (2015)
Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
Helna Pettersson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes
David Tamborero et al.
BIOINFORMATICS (2013)
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
Pablo Cingolani et al.
FLY (2012)
Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
Henrik Frederiksen et al.
BLOOD (2011)
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
Camilla Nielsen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
Elisa Rumi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?
Sylvie Hermouet et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
Damla Olcaydu et al.
NATURE GENETICS (2009)
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Outi Kilpivaara et al.
NATURE GENETICS (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
Benjamin F. Johnson et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Role of transforming growth factor-β in hematologic malignancies
Mei Dong et al.
BLOOD (2006)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
